omeprazole has been researched along with rhodamine 123 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sugawara, K; Takahata, T; Tateishi, T; Uno, T; Yasui-Furukori, N; Yoshiya, G | 1 |
Homma, M; Itagaki, F; Kobayashi, H; Kohda, Y; Ohnishi, N; Okamura, N; Sakaeda, T; Takara, K; Yagami, T; Yokoyama, T | 1 |
2 other study(ies) available for omeprazole and rhodamine 123
Article | Year |
---|---|
Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates.
Topics: Adult; Anti-Allergic Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Flow Cytometry; Fluorescent Dyes; Genotype; Humans; Lymphocytes; Male; Mixed Function Oxygenases; Omeprazole; Rhodamine 123; Terfenadine | 2004 |
Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Biological Transport; Caco-2 Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Dyes; HeLa Cells; Humans; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Rhodamine 123; Vinblastine | 2004 |